INDIAN authorities have given approval for a late-stage clinical trial of a protein-based Covid-19 vaccine candidate developed by Sanofi SA and GlaxoSmithKline Plc, the drugmakers said. France’s Sanofi and Britain’s…
Subscribe for our weekly news letter here!
You can unsubscribe us at any time